Ken Griffin Aptargroup, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$137.2 - $150.79 $54,879 - $60,316	-400 Reduced 7.69%	4,800 $675,000
Q1 2024 May 15, 2024	BUY	$122.88 - $144.66 $258,048 - $303,786	2,100 Added 67.74%	5,200 $748,000
Q4 2023 Feb 14, 2024	BUY	$121.17 - $128.59 $169,638 - $180,026	1,400 Added 82.35%	3,100 $383,000
Q3 2023 Nov 14, 2023	BUY	$112.47 - $132.89 $56,235 - $66,445	500 Added 41.67%	1,700 $212,000
Q2 2023 Aug 14, 2023	BUY	$112.49 - $121.7 $11,249 - $12,170	100 Added 9.09%	1,200 $139,000
Q1 2023 May 15, 2023	BUY	$109.21 - $120.25 $21,842 - $24,050	200 Added 22.22%	1,100 $130,000
Q4 2022 Feb 14, 2023	BUY	$93.98 - $110.93 $84,582 - $99,837	900 New	900 $98,000

504

62.6M

8.3K

3.3K

Ticker ATR
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 65,337,000
Market Cap $11.4B
Description
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.